CYTOKINETICS INC — Director's Dealing 2021

Nov 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-10-29

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-29	Common Stock	M	5000	$6.0	Acquired	365063	Direct
2021-10-29	Common Stock	S	5000	$35.7993	Disposed	360063	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-29	Incentive Stock Option (right to buy)	$6.0	M	5000	Disposed	2023-03-05	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2083	Indirect
Common Stock	2083	Indirect

Footnotes

F1: Amount of securities beneficially owned following reported transaction has been adjusted by 2500 shares representing shares owned by reporting person as a stockholder of record on August 26, 2013, which has previously not been included prior Form 4s as a result of a reporting error.

F2: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020.

F3: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP).

F4: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F5: Shares held by The Brittany Blum 2003 Irrevocable Trust.